Mark L. Berch

Array ( [id] => 754633 [patent_doc_number] => 07019002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Pyridopyrimidinones derivatives as telomerase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/310193 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42079 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/019/07019002.pdf [firstpage_image] =>[orig_patent_app_number] => 10310193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972326 [patent_doc_number] => 06936711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Process for preparation of penam derivatives from cepham derivatives' [patent_app_type] => utility [patent_app_number] => 10/309201 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4374 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936711.pdf [firstpage_image] =>[orig_patent_app_number] => 10309201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830411 [patent_doc_number] => 20030181469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound' [patent_app_type] => new [patent_app_number] => 10/296990 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7662 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181469.pdf [firstpage_image] =>[orig_patent_app_number] => 10296990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991476 [patent_doc_number] => 20050090513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Compounds specific to adenosine a1 and a3 receptors and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/497451 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29157 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090513.pdf [firstpage_image] =>[orig_patent_app_number] => 10497451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728712 [patent_doc_number] => 07041666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Adenosine A2a receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/304504 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17809 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041666.pdf [firstpage_image] =>[orig_patent_app_number] => 10304504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639715 [patent_doc_number] => 20030212059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Adenosine A2a receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/304931 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7772 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212059.pdf [firstpage_image] =>[orig_patent_app_number] => 10304931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865604 [patent_doc_number] => 20030191130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => '[1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/304939 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12053 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191130.pdf [firstpage_image] =>[orig_patent_app_number] => 10304939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 687270 [patent_doc_number] => 07078524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'Process for the synthesis of ganciclovir' [patent_app_type] => utility [patent_app_number] => 10/302798 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1866 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078524.pdf [firstpage_image] =>[orig_patent_app_number] => 10302798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835217 [patent_doc_number] => 20030162763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Novel cephalosporin compounds and process for preparing the same' [patent_app_type] => new [patent_app_number] => 10/296048 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5842 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162763.pdf [firstpage_image] =>[orig_patent_app_number] => 10296048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847755 [patent_doc_number] => 20030166922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Novel cephalosporin compounds and process for preparing the same' [patent_app_type] => new [patent_app_number] => 10/276960 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12150 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166922.pdf [firstpage_image] =>[orig_patent_app_number] => 10276960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835216 [patent_doc_number] => 20030162762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Novel cephalosporin compounds and process for preparing the same' [patent_app_type] => new [patent_app_number] => 10/276961 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13811 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162762.pdf [firstpage_image] =>[orig_patent_app_number] => 10276961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 907725 [patent_doc_number] => 07332600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'Process for the preparation of crystalline imipenem' [patent_app_type] => utility [patent_app_number] => 10/495681 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1486 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332600.pdf [firstpage_image] =>[orig_patent_app_number] => 10495681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034541 [patent_doc_number] => 20050033051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Nucleosides preparation thereof and use as inhibitors of rna viral polymerases' [patent_app_type] => utility [patent_app_number] => 10/496116 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8598 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20050033051.pdf [firstpage_image] =>[orig_patent_app_number] => 10496116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1063313 [patent_doc_number] => 06849737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-01 [patent_title] => 'Synthesis and purification of valacyclovir' [patent_app_type] => utility [patent_app_number] => 10/293347 [patent_app_country] => US [patent_app_date] => 2002-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5770 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849737.pdf [firstpage_image] =>[orig_patent_app_number] => 10293347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788189 [patent_doc_number] => 20030139428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'A2B adenosine receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/290921 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28325 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139428.pdf [firstpage_image] =>[orig_patent_app_number] => 10290921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7620012 [patent_doc_number] => 06943171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-13 [patent_title] => 'Polycyclic guanine derivative phosphodiesterase V inhibitors' [patent_app_type] => utility [patent_app_number] => 10/290011 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15994 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943171.pdf [firstpage_image] =>[orig_patent_app_number] => 10290011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1153048 [patent_doc_number] => 06767900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-27 [patent_title] => 'Phosphonate nucleotide compound' [patent_app_type] => B2 [patent_app_number] => 10/220126 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7254 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/767/06767900.pdf [firstpage_image] =>[orig_patent_app_number] => 10220126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1111355 [patent_doc_number] => 06806270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-19 [patent_title] => 'Selective antagonists of A2B adenosine receptors' [patent_app_type] => B2 [patent_app_number] => 10/285747 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5141 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806270.pdf [firstpage_image] =>[orig_patent_app_number] => 10285747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 460532 [patent_doc_number] => 07241890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => 'Purine analogs having HSP90-inhibiting activity' [patent_app_type] => utility [patent_app_number] => 10/494414 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 26964 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241890.pdf [firstpage_image] =>[orig_patent_app_number] => 10494414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913198 [patent_doc_number] => 20050176956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Process for the preparation of ganciclovir intermediate n2-acetyl-9-(1,3-diacetoxy-2-propoxymethyl) guanine' [patent_app_type] => utility [patent_app_number] => 10/492338 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3732 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176956.pdf [firstpage_image] =>[orig_patent_app_number] => 10492338 [rel_patent_id] =>[rel_patent_doc_number] =>)